en · de · es
cardarine-notes.peptides1004.com › Info › Detection And Regulatory Landscape — Beginner to Advanced

Detection And Regulatory Landscape — Beginner to Advanced

By Editorial Desk · published 2025-09-20 · last reviewed 2025-10-30 · Info

A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-10-30. Anything still debated is marked as such rather than presented as settled.

Detection and Regulatory Landscape

A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.

Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Cardarine at a glance

PropertyValueNotes
Regulatory statusProhibited in sportListed by WADA as a PPARδ agonist.
Typical detection matrixUrineMost common sample for anti-doping analysis.
Common analytical methodLC-MS/MSLiquid chromatography-tandem mass spectrometry.
Common synonymsGW501516, GSK-516, endurobolNames found in research and fitness contexts.
Typical detection windowVariableDepends on dose, route, and individual metabolism.

Identity and Regulatory Status

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Related pages on this site

Cardarine as Investigational PPARδ Agonist

Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.

The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.

Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.

Mechanism and Research Context

Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.

In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.

Supporting material

President Harry S. Truman began covertly authorizing direct financial assistance to the French, and on June 27, 1950, after the outbreak of the Korean War, announced publicly that the U.S. was doing so. On June 30, 1950, the first U.S. supplies for Indochina were delivered. In September, Truman sent the Military Assistance Advisory Group (MAAG) to Indochina to assist the French. Later, in 1954, U.S. President Dwight D. Eisenhower explained the escalation risk, introducing what he referred to as the "domino principle", which eventually became the concept of domino theory. After the Moch–Marshall meeting of September 23, 1950, in Washington, United States, started to support the French Union effort politically, logistically and financially. Officially, US involvement did not include use of armed force. As the situation at Dien Bien Phu deteriorated in 1954, France requested more support from the United States, including equipment and direct intervention. For instance, on April 4 French Prime Minister Joseph Laniel and Foreign Minister Georges Bidault conveyed to U.S. Ambassador C. Douglas Dillon that "immediate armed intervention of US carrier aircraft at DienBien Phu is now necessary to save the situation". The United States discussed with allies multiple options, including the use of nuclear weapons. A key concern in the planning was the response of China. While the planning continued, the United States moved an aircraft-carrier task-force, which included the carriers Boxer and Essex, into the South China Sea between the Philippines and Indochina.

Though catch bonds are now widely recognized, their mechanism of action is still under dispute. Two leading hypotheses dominate the discussion. The first hypothesis, the allosteric model, stems from evidence that x-ray crystallography of selectin proteins shows two conformational states: a bent conformation in the absence of ligand, and an extended conformation in the presence of the ligand. The main domains involved in these states are a lectin domain which contains the ligand binding site and an EGF domain which can shift between bent and extended conformations. The allosteric model claims that tension on the EGF domain favors the extended conformation, and extension of this domain causes a conformational shift in the lectin domain, resulting in greater binding affinity for the ligand. As a result of this conformational change, the ligand is effectively locked in place despite tension exerted on the bond.

=== Non-destructive testing === Nuclear magnetic resonance is extremely useful for analyzing samples non-destructively. Radio-frequency magnetic fields easily penetrate many types of matter and anything that is not highly conductive or inherently ferromagnetic. For example, various expensive biological samples, such as nucleic acids, including RNA and DNA, or proteins, can be studied using nuclear magnetic resonance for weeks or months before using destructive biochemical experiments. This also makes nuclear magnetic resonance a good choice for analyzing dangerous samples.

=== Excretion === The elimination of 2,6-DCBQ and its derivatives occurs predominantly through the renal system. Due to its high reactivity, levels of the unchanged parent compound are negligible. Instead, the compound is excreted in the form of water-soluble metabolites, specifically mercapturic acid derivatives. Biliary excretion is a secondary possibility, but urinary elimination remains the dominant pathway for the clearance of 2,6-DCBQ metabolites from the body.

Sources: en.wikipedia.org

Supporting material

Strategic Cyber Security, ISBN 978-9949-9040-7-5, 169 pages Halpern, Sue, "The Drums of Cyberwar" (review of Andy Greenberg, Sandworm: A New Era of Cyberwar and the Hunt for the Kremlin's Most Dangerous Hackers, Doubleday, 2019, 348 pp.), The New York Review of Books, vol. LXVI, no. 20 (19 December 2019), pp. 14, 16, 20. Harris, Shane (2014). @War: The Rise of the Military-Internet Complex. Eamon Dolan/Houghton Mifflin Harcourt. ISBN 978-0-544-25179-3. Hunt, Edward (2012). "US Government Computer Penetration Programs and the Implications for Cyberwar". IEEE Annals of the History of Computing. 34 (3): 4–21. Bibcode:2012IAHC...34c...4H. doi:10.1109/mahc.2011.82. S2CID 16367311. Kestner, Peter (2024). The Art of Cyber Warfare: Strategic and Tactical Approaches for Attack and Defense in the Digital Age (1st ed.). Wiesbaden: Springer. pp. XX, 292. doi:10.1007/978-3-658-43879-1. ISBN 978-3-658-43879-1. Janczewski, Lech; Colarik, Andrew M. (2007). Cyber Warfare and Cyber Terrorism. Idea Group Inc (IGI). ISBN 978-1-59140-992-2. Rid, Thomas (2012). "Cyber War Will Not Take Place". Journal of Strategic Studies. 35 (1): 5–32. doi:10.1080/01402390.2011.608939. S2CID 153828543. Springer, Paul J. (2025). Encyclopedia of Cyber Warfare (2nd ed.). New York: Bloomsbury Academic. p. 464. ISBN 9781440881619. Woltag, Johann-Christoph: 'Cyber Warfare' in Rüdiger Wolfrum (Ed.) Max Planck Encyclopedia of Public International Law (Oxford University Press 2012).

In contrast to other mechanical disruption methods the Microfluidizer breaks the cell membranes efficiently but gently, resulting in relatively large cell wall fragments (450 nm), and thus making it easier to separate the cell contents. This can lead to shorter filtration times and better centrifugation separation. Microfluidizer technology scales from one milliliter to thousands of liters.

In a clandestine setting, DMT is not typically synthesized due to the lack of availability of the starting materials, namely tryptamine and oxalyl chloride. Instead, it is more often extracted from plant-sources using a nonpolar hydrocarbon solvent such as naphtha or heptane, and a base such as sodium hydroxide. Alternatively, an acid-base extraction is sometimes used instead. A variety of plants contain DMT at sufficient levels for being viable sources such as Mimosa tenuiflora, Acacia acuminata, Acacia confusa, Acacia maidenii, Arundo donax, 'Diplopterys cabrerana, Psychotria viridis. The chemicals involved in the extraction are commonly available. The plant-material may be illegal to procure in some countries. The end-product (DMT) is illegal in most countries.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine banned in sports?

Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.

How is cardarine detected?

Detection usually uses liquid chromatography-tandem mass spectrometry after sample cleanup. Laboratories look for the parent compound or metabolites. The method requires validated reference standards and controls.

Is cardarine legal to buy?

Legality varies by country. In many places it is an unapproved drug and cannot be legally sold for human consumption. Purchasing from online vendors carries legal and quality risks.

Is cardarine approved for human use?

No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.

Network